SARS-CoV-2 (COVID-19) Testing Service
UKAS accredited service laboratory for processing COVID-19 tests
Viral RNA extraction, qRT-PCR and rapid whole genome sequencing workflows for detection of all known variants of SARS-CoV-2
Our high throughput service facility can perform up to 5000 qRT-PCR COVID-19 tests per day ensuring test results are delivered quickly and efficiently.
If you are looking for a high throughput UK laboratory to process your SARS-CoV-2 (COVID-19) tests, we can help.
Service Capabilities
Viral RNA extraction service
Our viral RNA extraction service isolates viral RNA from nasopharyngeal swabs or other biofluids. We use a magnetic bead-based technology which is ideally suited to high through-put processing and enables us to carry out extractions at scale. The purification of high-quality RNA free from protein and other impurities is required for downstream qRT-PCR or rapid viral whole genome sequencing (WGS).
Find out more about VirPath RNA extraction kit for COVID-19 testing laboratories.
SARS-CoV-2 multiplex qRT-PCR service
Our SARS-CoV-2 qRT-PCR service uses VirPath SARS-CoV-2 Multiplex qRT-PCR Kit. This kit is CE-IVD marked and is one of the few COVID-19 qRT-PCR tests to pass the stringent accuracy and sensitivity requirements set for Fit to Fly, Day 2 testing and general COVID-19 testing.
Detects all known variants
CE-IVD marked
Approved for Day 2 testing
Find out more about VirPath Multiplex qRT-PCR kit for COVID-19 testing laboratories.
SARS-CoV-2 whole genome sequencing
We have over 6 years of experience in developing and manufacturing sequencing products and delivering sequencing services for diagnostic testing. In May 2020 our sister company, Nonacus was funded by the UK Government (Innovate UK) to develop a novel rapid method for whole genome sequencing for viral surveillance which means we are well placed to offer customers this as a service.
SARS-CoV-2 WGS service
Our WGS service uses a robust and rapid method for whole genome sequencing of the SARS-CoV-2 virus that is ideally suited for Day 2 testing and will deliver data that meet the required standards:
All samples with cycle threshold (CT) values of <30 (defined as equivalent to ~10,000-1,000 viral genome copies/ml) will be sequenced.
